Margin width is not predictive of residual disease on re-excision in breast conserving therapy

Journal of Surgical Oncology
L Hadzikadic GusicG M Ahrendt

Abstract

There is lack of consensus regarding re-excision in breast-conserving therapy (BCT) and close margins. We hypothesize that margin width does not predict residual disease. The cancer registry was queried from 2003 to 2008 for patients with BCT who underwent re-excision for <2-mm margins. Factors associated with additional disease were evaluated. One thousand eight hundred forty-three patients underwent BCT. Our re-excision rate was 42%. Clinicopathologic factors from 228 patients were analyzed. One hundred five patients (46%) had additional disease; of those, 58% had BCT and 42% mastectomy. One hundred twenty-three (54%) had no additional disease; of those 82% had BCT and 18% mastectomy. Of the 66 patients who underwent mastectomy, 44 (67%) had residual disease; of the 161 who had BCT, 61 (38%) had residual disease (P < 0.01). On univariate analysis, margin width did not correlate with residual disease. Multifocality, non-invasive histology, increasing number of close margins, and higher grade predicted additional disease (P < 0.05). On multivariate analysis, only number of close margins remained significant. Margin width does not predict additional disease. This challenges the practice of using this to select re-excision candid...Continue Reading

References

Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa A Newman, Henry M Kuerer
Jun 14, 2006·Cancer·Gordon F SchwartzUNKNOWN Consensus Conference Committee
Aug 10, 2007·Breast Cancer Research and Treatment·Salomone Di SaverioMario Taffurelli
Dec 10, 2008·Journal of Surgical Oncology·Michael S SabelLisa A Newman
Oct 23, 2009·Annals of Surgical Oncology·Michelle AzuMonica Morrow
Sep 8, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nehmat HoussamiLawrence J Solin
Nov 4, 2010·Annals of Surgical Oncology·Anne KobbermannRoshni Rao
Feb 3, 2012·JAMA : the Journal of the American Medical Association·Laurence E McCahillAdedayo A Onitilo
Mar 24, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S O GurdalV Ozmen
Sep 27, 2012·Annals of Surgical Oncology·Melissa S CampBarbara L Smith
Aug 27, 2013·Annals of Surgical Oncology·Theresa SchwartzJeffrey Landercasper

❮ Previous
Next ❯

Citations

Jan 28, 2014·Journal of Surgical Oncology·Julie O'Brien, Monica Morrow
Jul 28, 2017·Journal of Surgical Oncology·Caitlin R PattenRichard L White
May 12, 2018·Annals of Surgical Oncology·Lisa J Findlay-ShirrasMaged Nashed
Jan 25, 2019·Scientific Reports·Cristina BausAlbert Costa
Jun 17, 2021·Breast Cancer Research and Treatment·Julie B SiegelAndrea M Abbott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Journal of Surgical Oncology
Michael S SabelLisa A Newman
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Nehmat HoussamiLawrence J Solin
© 2021 Meta ULC. All rights reserved